New screening tool aims to catch hidden arthritis in psoriasis patients

NCT ID NCT06382051

Recruiting now Diagnosis Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 17, 2026 · Updated 4 times

Summary

This Canadian study tests whether adding two questions about morning stiffness and lower back pain to a standard screening tool (PEST) can help dermatologists identify psoriatic arthritis earlier in people with moderate-to-severe plaque psoriasis. About 502 adults who are candidates for biologic medications will complete the screening, and those flagged will see a rheumatologist for confirmation. The goal is to improve early diagnosis and prevent joint damage.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PEST screening tool with two additional questions
What this could lead to: If successful, this could lead to a better screening tool that helps dermatologists identify psoriatic arthritis earlier in psoriasis patients.
What could go wrong: This is an observational study, not a treatment trial. The new screening questions may not significantly improve detection rates, and results may not apply outside Canada.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psoriasis psoriatic arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PLAQUE PSORIASIS PSORIATIC ARTHRITIS

Contacts and locations

Locations

Novartis Investigative Site
RECRUITING

Calgary, Alberta, T2J 7E1, Canada
Novartis Investigative Site
RECRUITING

Edmonton, Alberta, T5J 3S9, Canada
Novartis Investigative Site
RECRUITING

Edmonton, Alberta, T6G 2C8, Canada
Novartis Investigative Site
RECRUITING

Kelowna, British Columbia, V1W 4V5, Canada
Novartis Investigative Site
RECRUITING

Surrey, British Columbia, V3R 6A7, Canada
Novartis Investigative Site
RECRUITING

Winnipeg, Manitoba, R3C 0N2, Canada
Novartis Investigative Site
RECRUITING

Fredericton, New Brunswick, E3B 1G9, Canada
Novartis Investigative Site
RECRUITING

Barrie, Ontario, L4M 6L2, Canada
Novartis Investigative Site
RECRUITING

Greater Sudbury, Ontario, P3C 1X8, Canada
Novartis Investigative Site
RECRUITING

Hamilton, Ontario, L8J 0G5, Canada
Novartis Investigative Site
RECRUITING

Hamilton, Ontario, L8N 1V6, Canada
Novartis Investigative Site
RECRUITING

Hamilton, Ontario, L8P4B4, Canada
Novartis Investigative Site
RECRUITING

London, Ontario, N6A 5R9, Canada
Novartis Investigative Site
RECRUITING

London, Ontario, N6G 0W7, Canada
Novartis Investigative Site
RECRUITING

Markham, Ontario, L3R 2C7, Canada
Novartis Investigative Site
RECRUITING

Ottawa, Ontario, K2A 3Z3, Canada
Novartis Investigative Site
RECRUITING

Richmond Hill, Ontario, L4C 9M7, Canada
Novartis Investigative Site
RECRUITING

Stoney Creek, Ontario, L8G 1H1, Canada
Novartis Investigative Site
RECRUITING

Toronto, Ontario, M4A2S8, Canada
Novartis Investigative Site
RECRUITING

Toronto, Ontario, M5S 1B6, Canada
Novartis Investigative Site
RECRUITING

Waterloo, Ontario, N2J 1C4, Canada
Novartis Investigative Site
RECRUITING

Montreal, Quebec, H1T 2M4, Canada
Novartis Investigative Site
RECRUITING

Montreal, Quebec, H1Y 3L1, Canada
Novartis Investigative Site
RECRUITING

Montreal, Quebec, H4A 3T2, Canada
Novartis Investigative Site
RECRUITING

Québec, Quebec, G1V 4X7, Canada
Novartis Investigative Site
RECRUITING

Québec, Quebec, G1W 4R4, Canada
Novartis Investigative Site
RECRUITING

Ste-Foy, Quebec, G1V 4G2, Canada
Novartis Investigative Site
RECRUITING

Verdun, Quebec, H4G 3E7, Canada
Novartis Investigative Site
RECRUITING

Saskatoon, Saskatchewan, S7K 2C1, Canada
Novartis Investigative Site
RECRUITING

Saskatoon, Saskatchewan, S7K0H6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.